Acumen Pharmaceuticals Inc (ABOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Operating Expenses | 123,832 | 114,017 | 61,138 | 45,237 | 19,584 |
| Operating Income | -123,832 | -114,017 | -61,138 | -45,237 | -19,584 |
| Interest Expense | 4,224 | 4,068 | 581 | 0 | 0 |
| Other Income | 6,721 | 15,756 | 9,348 | 2,381 | -81,022 |
| Pre-tax Income | -121,335 | -102,329 | -52,371 | -42,856 | -100,606 |
| Net Income Continuous | -121,335 | -102,329 | -52,371 | -42,856 | -100,606 |
| Net Income | $-121,335 | $-102,329 | $-52,371 | $-42,856 | $-100,606 |
| EPS Basic Total Ops | -2.00 | -1.71 | -1.08 | -1.06 | -5.02 |
| EPS Basic Continuous Ops | -2.00 | -1.71 | -1.08 | -1.06 | -5.02 |
| EPS Diluted Total Ops | -2.00 | -1.71 | -1.08 | -1.06 | -5.02 |
| EPS Diluted Continuous Ops | -2.00 | -1.71 | -1.08 | -1.06 | -5.02 |
| EPS Diluted Before Non-Recurring Items | N/A | -1.71 | -1.08 | -1.06 | -2.13 |
| EBITDA(a) | $-124,457 | $-118,854 | $-64,075 | $-44,581 | $-19,425 |